Omalizumab — Discount Pricing
Omalizumab is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Omalizumab Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $131.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Omalizumab
Omalizumab is a prescription medication. Ask your doctor if Omalizumab is right for you.
How to Check Omalizumab Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Omalizumab at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Respiratory & Allergies
About Omalizumab
Omalizumab, often known by its brand name Xolair, is a vital biologic medication for managing severe allergic conditions. If you or a loved one relies on this advanced treatment, you know its importance—and its cost. At TheDrugClub, we're dedicated to helping our members access crucial medications like omalizumab more affordably, making relief more attainable.
Omalizumab, marketed as Xolair, is a specialized biologic medication designed to treat specific severe allergic conditions when other treatments haven't provided sufficient relief. It offers a targeted approach for individuals struggling with its debilitating effects.
What Omalizumab Treats
This medication is approved for several challenging conditions:
- Severe Allergic Asthma: For individuals aged 6 and older whose asthma is not well-controlled by inhaled corticosteroids.
- Chronic Idiopathic Urticaria (CIU) / Chronic Spontaneous Urticaria (CSU): For those aged 12 and older who continue to have chronic hives despite antihistamine treatment.
- Nasal Polyps: For adults aged 18 and older when other treatments have been ineffective.
By addressing the underlying allergic response, omalizumab can significantly improve quality of life for patients with these conditions.
How Omalizumab Works
Omalizumab is a monoclonal antibody. This means it's a lab-produced protein designed to mimic the antibodies your body naturally makes. Specifically, omalizumab targets and binds to immunoglobulin E (IgE), an antibody that plays a key role in allergic reactions. By binding to IgE, omalizumab prevents it from attaching to
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Omalizumab is approved for (FDA label)
XOLAIR is an anti-IgE antibody indicated for: Moderate to severe persistent asthma in adults and pediatric patients 6 years of age and older with a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with inhaled corticosteroids ( 1.1 ) Chronic rhinosinusitis with nasal polyps (CRSwNP) in adult patients 18 years of age and older with inadequate response to nasal corticosteroids, as add-on maintenance treatment ( 1.2 ) IgE-mediated food allergy in adult and pediatric patients aged 1 year and older for the reduction of allergic reactions (Type I), including anaphylaxis, that may occur with accidental exposure to one or more foods.
Source: Read the full FDA label on DailyMed. Label effective date: August 13, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.